DOCSLIB.ORG

Illicit Recreational Drugs and Sleep

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Illicit Recreational Drugs and Sleep Aus der Universitätsklinik für Psychiatrie und Psychosomatik der Albert-Ludwigs-Universität Freiburg i.Br. Illicit Recreational Drugs and Sleep A systematic review covering cocaine, ecstasy, LSD and cannabis INAUGURAL - DISSERTATION zur Erlangung des Medizinischen Doktorgrades der Medizinischen Fakultät der Albert-Ludwigs-Universität Freiburg i.Br. Vorgelegt 2007 von Thomas Schierenbeck geboren in Greven II Dekan Prof. Dr. med. Christoph Peters 1. Gutachter Prof. Dr. med. Mathias Berger 2. Gutachter Prof. Dr. med. Dr. rer. nat. Klaus Aktories Jahr der Promotion 2008 III Dedicated to Suzanne Ora Smith * 1955 † 2006 IV Table of Contents Abbreviations.......................................................................................................... VII 1. Introduction............................................................................................................1 1.1. Objectives of this dissertation.......................................................................1 1.2. Background.....................................................................................................2 1.2.1. Cocaine ......................................................................................................2 1.2.1.1. History................................................................................................. 2 1.2.1.2. Chemical structure .............................................................................. 3 1.2.1.3. Pharmacokinetics................................................................................ 3 1.2.1.4. Pharmacodynamics ............................................................................ 3 1.2.2. 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) and 3,4- Methylenedioxy-N-ethylamphetamine (MDE, “Eve”) ........................................... 5 1.2.2.1. History................................................................................................. 5 1.2.2.2. Chemical structure .............................................................................. 6 1.2.2.3. Pharmacokinetics................................................................................ 6 1.2.2.4. Pharmacodynamics ............................................................................ 6 1.2.3. D-Lysergic acid diethylamide (LSD) ...........................................................7 1.2.3.1. History................................................................................................. 7 1.2.3.2. Chemical structure .............................................................................. 7 1.2.3.3. Pharmacokinetics................................................................................ 8 1.2.3.4. Pharmacodynamics ............................................................................ 8 1.2.4. Cannabis ....................................................................................................9 1.2.4.1. History................................................................................................. 9 1.2.4.2. Chemical structure .............................................................................. 9 1.2.4.3. Pharmacokinetics.............................................................................. 10 1.2.4.4. Pharmacodynamics .......................................................................... 10 2. Materials and Methods........................................................................................13 2.1. Search strategy.............................................................................................13 2.1.1. Electronic databases ................................................................................13 2.1.2. Key words.................................................................................................13 2.2. Study selection and data extraction............................................................13 V 2.3. Statistical methods .......................................................................................14 3. Results..................................................................................................................15 3.1. Identification of studies................................................................................15 3.1.1. Trial flow...................................................................................................15 3.1.2. Quality assessment ..................................................................................17 3.2. Effects of illicit recreational drugs upon sleep ..........................................19 3.2.1. Cocaine ....................................................................................................19 3.2.1.1. Study characteristics......................................................................... 19 3.2.1.2. Preclinical studies ............................................................................. 19 3.2.1.3. PSG studies of cocaine administration and withdrawal..................... 21 3.2.1.4. Meta-analysis of objective sleep measures during acute and subacute cocaine withdrawal......................................................................................... 30 3.2.1.5. Studies measuring subjective effects of cocaine upon sleep ............ 33 3.2.1.6. Sleep effects of prenatal cocaine exposure ...................................... 40 3.2.1.7. Overview over effects of cocaine upon sleep.................................... 44 3.2.2. 3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”) and 3,4- Methylenedioxy-N-ethylamphetamine (MDE; “Eve”) ......................................... 45 3.2.2.1. Study characteristics......................................................................... 45 3.2.2.2. Preclinical studies ............................................................................. 46 3.2.2.3. PSG studies of MDMA/MDE intake................................................... 46 3.2.2.4. Studies assessing subjective effects of ecstasy upon sleep ............. 49 3.2.2.5. Overview over sleep effects of ecstasy............................................. 52 3.2.3. D-Lysergic acid diethylamide (LSD) .........................................................53 3.2.3.1. Study characteristics......................................................................... 53 3.2.3.2. Preclinical studies ............................................................................. 53 3.2.3.3. PSG studies of LSD ingestion........................................................... 57 3.2.3.4. Overview over effects of LSD upon sleep ......................................... 60 3.2.4. Cannabis ..................................................................................................60 3.2.4.1. Study characteristics......................................................................... 60 3.2.4.2. Preclinical studies ............................................................................. 61 3.2.4.3. Studies measuring objective sleep effects of cannabis in humans ... 67 3.2.4.4. Studies assessing subjective sleep effects of cannabis.................... 77 3.2.4.5. Effects of gestational cannabis exposure upon sleep ....................... 87 VI 3.2.4.6. Overview over sleep effects of cannabis........................................... 89 3.3. Effects of sleep disturbances upon vulnerability to substance use ........90 3.3.1. Study characteristics ................................................................................90 3.3.2. Impact of sleep disturbances upon vulnerability to subsequent onset of drug abuse ........................................................................................................ 91 3.3.3. Predictive value of sleep disturbances for relapse ...................................97 4. Discussion ...........................................................................................................99 4.1. Principal findings and their implications ....................................................99 4.1.1. Impact of illicit recreational drugs upon sleep...........................................99 4.1.1.1. Cocaine............................................................................................. 99 4.1.1.2. MDMA and MDE ............................................................................. 103 4.1.1.3. LSD................................................................................................. 104 4.1.1.4. Cannabis......................................................................................... 105 4.1.2. Effects of sleep disturbances upon propensity for drug abuse ...............107 4.2. Limitations of this review ...........................................................................109 5. Summary ............................................................................................................112 6. Zusammenfassung............................................................................................113 7. References .........................................................................................................114 VII Abbreviations CBD cannabidiol d day DB double-blind DSM-IV Diagnostic and Statistical Manual of Mental Disorders, fourth edition EA early abstinence EEG electroencephalogram EMG electromyogram EOG electrooculogram h hour HIV human immunodeficiency virus i.v. intravenous (route of administration) LA late abstinence LSD lysergic acid diethylamide MDE methylenedioxyethamphetamine MDEA =MDE (methylenedioxyethamphetamine) MDMA methylenedioxymethamphetamine
Load more

Recommended publications
  • Sleep Parameters During Polysomnography and Continuous Positive Airway Pressure Titration in Severe Obstructive Sleep Apnea Adult Patients
    ISSN: 2455-1759 DOI: https://dx.doi.org/10.17352/aor CLINICAL GROUP Received: 30 June, 2021 Research Article Accepted: 24 July, 2021 Published: 26 July, 2021 *Corresponding author: Utku Kubilay, MD, Sleep parameters during Department of Otorhinolaryngology, Ekol Hospital, Istanbul, 8211/11 Sk.No:4 Daire 8, Izmir/Cigli, Turkey, Tel: +90 536 844 86 52; polysomnography and E- mail: Keywords: Obstructive sleep apnea syndrome; continuous positive airway Continuous positive airway pressure; REM sleep; REM density pressure titration in severe https://www.peertechzpublications.com obstructive sleep apnea adult patients Utku Kubilay* Department of Otorhinolaryngology, Ekol Hospital, Istanbul, Turkey Abstract Objectives: The aim of the present study was to demonstrate the effect of continuous positive airway pressure treatment on sleep parameters in severe obstructive sleep apnea patients. Patients/methods: Data regarding apnea-hypopnea index, total sleep time, sleep effi ciency, rapid-eye-movement (REM) density, REM latency, total REM episodes during polysomnography and continuous positive airway pressure titration according to the obstructive sleep apnea severity were compared. Results: Of the 51 patients whose charts were reviewed, the average age was 46.47±10.62 years and the mean body mass index was 31.71±4.97 kg/m2. Thirty-two patients who had an apnea-hypopnea index between 30 and 60/h included to the Group 1 and 19 patients who had an apnea-hypopnea index ≥60/h included to the Group 2. Among all studied parameters, only rapid-eye-movement latency showed statistical signifi cance between the studied groups. Changes in rapid-eye-movement latency differed signifi cantly among patients during polysomnography and continuous positive airway pressure titration in Group 2 (p=0.003).
    [Show full text]
  • Chapter 2 – Normal Human Sleep : an Overview Mary A
    Carskadon, M.A., & Dement, W.C. (2011). Monitoring and staging human sleep. In M.H. Kryger, T. Roth, & W.C. Dement (Eds.), Principles and practice of sleep medicine, 5th edition, (pp 16-26). St. Louis: Elsevier Saunders. Chapter 2 – Normal Human Sleep : An Overview Mary A. Carskadon, William C. Dement Abstract Normal human sleep comprises two states—rapid eye movement (REM) and non–REM (NREM) sleep— that alternate cyclically across a sleep episode. State characteristics are well defined: NREM sleep includes a variably synchronous cortical electroencephalogram (EEG; including sleep spindles, K- complexes, and slow waves) associated with low muscle tonus and minimal psychological activity; the REM sleep EEG is desynchronized, muscles are atonic, and dreaming is typical. A nightly pattern of sleep in mature humans sleeping on a regular schedule includes several reliable characteristics: Sleep begins in NREM and progresses through deeper NREM stages (stages 2, 3, and 4 using the classic definitions, or stages N2 and N3 using the updated definitions) before the first episode of REM sleep occurs approximately 80 to 100 minutes later. Thereafter, NREM sleep and REM sleep cycle with a period of approximately 90 minutes. NREM stages 3 and 4 (or stage N3) concentrate in the early NREM cycles, and REM sleep episodes lengthen across the night. Age-related changes are also predictable: Newborn humans enter REM sleep (called active sleep) before NREM (called quiet sleep) and have a shorter sleep cycle (approximately 50 minutes); coherent sleep stages emerge as the brain matures during the first year. At birth, active sleep is approximately 50% of total sleep and declines over the first 2 years to approximately 20% to 25%.
    [Show full text]
  • The Sleep-Loss Epidemic Accreditation
    ACCREDITATIONS EXAMINATION Please mark the correct answer clearly and keep a copy for your records. This course is sponsored by the Institute for Natural Resources (INR). INR is a non-profit, scientific organization dedicated to research and education in the fields of health and medicine. INR has no ties to any commercial organizations, does not solicit or receive any grants or gifts from any source, and has no connections with any religious, Multiple Choice food, food supplement, or political entity. 1. An animal that does NOT sleep on one side of the brain at 11. The most common sleep disorder in the American population is: Target Audience: Nurses, Pharmacists, Dietitians, Social Workers, Mental Health Professionals, Occupational a time is a: a) insomnia Therapists, Physical Therapists, and allied Health Professionals. a) beluga whale b) sea otter b) restless legs syndrome Please refer to the table below for the organizations that have approved the Institute for Natural Resources as a c) dolphin d) fur seal c) sleep apnea sponsor of continuing education. You may wish to check with your own licensing board to determine whether the 2. The Reticular Activating System or RAS that activates the d) REM behavior sleep disorder accreditations listed are acceptable to your board. For the most updated accreditation information, please contact cerebral cortex and promotes wakefulness is located in the: INR at [email protected]. 12. The DSM-5 diagnosis of Obstructive Sleep Apnea requires a) lower brain stem b) upper brain stem polysomnography showing an Apnea/Hypopnea Index or Level of instruction: Intermediate c) thalamus d) hypothalamus AHI of: PROFESSIONAL GROUP ACCREDITING ORGANIZATIONS 3.
    [Show full text]
  • Alcohol's Effects on Sleep in Alcoholics
    Alcohol’s Effects on Sleep in Alcoholics Kirk J. Brower, M.D. Sleep problems, which can have significant clinical and economic consequences, are more common among alcoholics than among nonalcoholics. During both drinking periods and withdrawal, alcoholics commonly experience problems falling asleep and decreased total sleep time. Other measures of sleep are also disturbed. Even alcoholics who have been abstinent for short periods of time (i.e., several weeks) or extended periods of time (i.e., several years) may experience persistent sleep abnormalities. Researchers also found that alcoholics are more likely to suffer from certain sleep disorders, such as sleep apnea. Conversely, sleep problems may predispose some people to developing alcohol problems. Furthermore, sleep problems may increase the risk of relapse among abstinent alcoholics. KEY WORDS: sleep disorder; AOD (alcohol or other drug) dependence; physiological AODE (effects of AOD use, abuse, and dependence); REM (rapid eye movement) sleep; AOD withdrawal syndrome; AOD abstinence; self medication; AODD (AOD use disorder) relapse; melatonin; treatment and maintenance; literature review leep problems1 are more common All of these terms refer both to subjec­ alcoholics than in nonalcoholics—has among alcoholics than among non- tive complaints about sleep, such as been associated with increased mortality Salcoholics (Aldrich 1998; Ehlers insomnia, and to objectively measured from heart disease and stroke (Aldrich 2000; National Institute on Alcohol Abuse abnormalities in sleep, which
    [Show full text]
  • Medication and Substance Abuse Timothy Roehrs; Thomas Roth
    Chapter 140 Medication and Substance Abuse Timothy Roehrs; Thomas Roth Chapter Highlights • Most psychoactive drugs with abuse • Some of the drugs of abuse are legal and widely liability have effects on sleep and used socially and may be the cause of patients’ wakefulness. sleep or alertness complaints. • The mechanisms underlying substance abuse • Other drugs with abuse liability are drugs are known, but the role of the drug’s sleep-wake indicated in the treatment of sleep disorders. state–altering effects in substance abuse is • This chapter provides guidelines for sleep not fully known, although it is likely to be disorders clinicians to differentiate drug-seeking important. behavior from therapy-seeking behavior. Various legal medications and all illegal central nervous system criteria is important for referral decisions. Substance abuse (CNS)–acting drugs have a high abuse liability, that is, the and dependence are common, as 18% of the U.S. population likelihood for development of physiologic or behavioral will experience a substance abuse disorder during their life- dependence on these substances is heightened. The various time, and about 20% of patients in general medical practice terms often used in discussing substance abuse are confusing, and 35% of psychiatric patients present with substance abuse are controversial, and need clarification. Physiologic depen- disorders. dence is a state induced by repeated drug use that results in a Virtually all drugs with a high abuse liability have pro- withdrawal syndrome when the drug is discontinued or an found effects on sleep and wake. For this reason, sleep disor- antagonist is administered. Many legal medications and illegal ders clinicians should assess all the drug-taking behavior of drugs can produce physiologic dependence, although the syn- their patients, including prescribed and over-the-counter drome intensity, relation to dose, and necessary duration of drugs, recreational drugs, tobacco and caffeine, health foods, use vary among different drugs.
    [Show full text]
  • Abbreviations Xxxi
    Abbreviations xxxi Abbreviations AASM: American Academy of Sleep Medicine DSM-IV: Diagnostic and Statistical Manual of Mental ACC: anterior cingulate cortex Disorders, 4th Edition Ach: acetylcholine DSPS: delayed sleep phase syndrome ACTH: adrenocorticotropic hormone DSPT: delayed sleep phase type AD-ACL: Activation-Deactivation Adjective Check List DTs: delirium tremens ADHD: attention-deficit-hyperactivity disorder DU: duodenal ulcer AHI: apnea-hypopnea index ECG: electrocardiogram/electrocardiographic AIM: ancestry informative marker EDS: excessive daytime sleepiness AMPA: α-amino-3hydroxy-5-methylisozazole-4- EEG: electroencephalogram, electroencephalographic propionic acid EMG: electromyogram AMPK: adenosine-monophosphate-activated protein ENS: enteric nervous system kinase EOG: electrooculogram AMS: acute mountain sickness EPS: extrapyramidal side effects (s) ANS: autonomic nervous system EPSP: excitatory postsynaptic potential ASPS: advanced sleep phase syndrome ERP: event-related potential ASPT: advanced sleep phase type ESS: Epworth Sleepiness Scale AW: active wakefulness FAID: Fatigue Audit InterDyne BA: Brodman area 18FDG: 2-deoxy-2-[18F]fluoro-d-glucose BAC: blood alcohol content F-DOPA: 6-[18F]fluoro-l-dopa BCOPS: Buffalo Cardio-Metabolic occupational Police FEV1: forced expiratory volume in 1 second Stress FIRST: Ford Insomnia Response to Stress Test BF: basal forebrain fMRI: functional magnetic resonance imaging BMAL1: brain and muscle ARNT-like FOQA: flight operations quality assurance BMI: body mass index FOSQ: Functional
    [Show full text]
  • Sleep and Sleep Disorders in Horses
    NEUROLOGY Sleep and Sleep Disorders in Horses Monica Aleman, MVZ, PhD, Diplomate ACVIM; D. Colette Williams, BS; and Terrell Holliday, DVM, PhD, Diplomate ACVIM Sleep in the horse is essential for its overall health. Sleep disorders and lack of sleep can seriously compromise horses’ physical activity and even worse, quality of life. Limited information and lack of understanding of sleep and associated disorders may lead to inaccurate diagnosis and managemen- t. Authors’ addresses: Department of Medicine and Epidemiology, Tupper Hall 2108, One Shields Avenue, School of Veterinary Medicine, University of California at Davis, CA 95616 (Aleman); The William R. Pritchard Veterinary Medical Teaching Hospital, One Shields Avenue, School of Veterinary Medicine, University of California at Davis, Davis, CA 95616 (Williams); and Department of Surgical and Radiological Sciences, One Shields Avenue, School of Veterinary Medicine, University of California at Davis, CA 95616 (Holliday); e-mail: [email protected] (Aleman). © 2008 AAEP. 1. Introduction the horse is profoundly limited; furthermore, sleep Sleep is important to our health; the same is true for disorders are even less understood, which may re- horses. However, horses require far less sleep than sult in controversy and sometimes, misdiagnosis most humans, averaging a total of only 3–5 h/day.1 and inaccurate management. In addition, sleep Foals, especially neonatal foals, sleep more per day disorders or simply a lack of sleep may seriously than adult horses. Their periods of sleep are more impair a horse’s physical activity and quality of life. numerous, longer, and more frequent than those of Sound sleep is essential for the overall health of our adult horses.
    [Show full text]
  • Extreme REM Rebound During Continuous Positive Airway Pressure Titration for Obstructive Sleep Apnea in a Depressed Patient
    Hindawi Publishing Corporation Case Reports in Medicine Volume 2014, Article ID 292181, 4 pages http://dx.doi.org/10.1155/2014/292181 Case Report Extreme REM Rebound during Continuous Positive Airway Pressure Titration for Obstructive Sleep Apnea in a Depressed Patient Anna Lo Bue, Adriana Salvaggio, Giuseppe Insalaco, and Oreste Marrone Institute of Biomedicine and Molecular Immunology, NationalResearchCouncil,ViaUgoLaMalfa153,90146Palermo,Italy Correspondence should be addressed to Anna Lo Bue; [email protected] Received 21 February 2014; Accepted 6 April 2014; Published 4 May 2014 Academic Editor: Mamede de Carvalho Copyright © 2014 Anna Lo Bue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A 20% increase in REM sleep duration has been proposed as a threshold to identify REM rebound in patients with obstructive sleep apnea (OSA) who start continuous positive airway pressure (CPAP) treatment. We describe the case of one patient with OSA who showed an unexpectedly high degree of REM rebound during titration of CPAP. A 34-year-old man was diagnosed with OSA. He remained untreated for many years, during which he developed systemic hypertension, depression, and severe daytime somnolence. When he was reevaluated sixteen years later, his Epworth sleepiness score was 18, and his OSA had greatly worsened (apnea/hypopnea index: 47, lowest nocturnal saturation: 57%). He underwent a successful CPAP titration during nocturnal polysomnography. Electroencephalographic analysis of the sleep recording revealed a huge amount of REM sleep, accounting for 72% of the total sleep time.
    [Show full text]
  • Physiology of Normal Sleep: from Young to Old
    Ann Natl Acad Med Sci (India), 49(3&4): 81-91, 2013 Physiology of Normal Sleep: From Young to Old V. Mohan Kumar Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala State ABSTRACT Human sleep, defined on the basis of electroencephalogram (EEG), electromyogram (EMG) and electrooculogram (EOG), is divided into rapid eye movement (REM) sleep and four stages of non–rapid eye movement (NREM) sleep. Collective monitoring and recording of physiological data during sleep is called polysomnography. Sleep which normally starts with a period of NREM alternates with REM, about 4-5 times, every night. Sleep pattern changes with increasing age. Newborns sleep for about 14-16 hours in a day of 24 hours. Although there is a wide variation among individuals, sleep of 7-8.5 hours is considered fully restorative in adults. Apart from restorative and recovery function, energy conservation could be one of the functions of sleep. The role of sleep in neurogenesis, memory consolidation and brain growth has been suggested. Though progress in medical science has vastly improved our understanding of sleep physiology, we still do not know all the functions of sleep. Key words : electroencephalogram, electromyogram, electrooculogram, polysomnography, REM sleep, non–REM sleep, newborns, circadian rhythm, auto- regulation, sleep function Correspondence : Dr. V. Mohan Kumar, 8-A, Heera Gate Apartments, DPI Junction, Jagathy, Trivandrum – 695014. 82 V. Mohan Kumar Sleep is quantified and qualified stages. They are stages 1, 2, 3 and 4 of on the basis of electrophysiological NREM sleep and REM sleep (Figure 2). signals. There are definite changes T he American Academy of Sleep in electroencephalogram (EEG), Medicine (AASM) modified the staging e l e c t r o m y o g r a m ( E M G ) a n d rules in 2007(4).
    [Show full text]
  • Polysomnographic Sleep Disturbances in Nicotine, Caffeine, Alcohol, Cocaine, Opioid, and Cannabis Use: a Focused Review
    The American Journal on Addictions, 24: 590–598, 2015 Copyright © American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12291 Polysomnographic Sleep Disturbances in Nicotine, Caffeine, Alcohol, Cocaine, Opioid, and Cannabis Use: A Focused Review Alexandra N. Garcia, BHS, MD Candidate, Ihsan M. Salloum, MD, MPH Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida Background and Objectives: In the United States, approximately 60 chronic sleep problems and disorders.2 Lack of sleep is strongly million Americans suffer from sleep disorders and about 22 million associated with chronic diseases such as hypertension, obesity, Americans report substance dependence or use disorders annually. 2 Sleep disturbances are common consequences of substance use diabetes, cardiovascular heart disease, and stroke. disorders and are likely found in primary care as well as in specialty Lack of sleep is also associated with negative effects on practices. The aim of this review was to evaluate the effects of the mental health. Research shows that individuals with chronic most frequently used substances—nicotine, alcohol, opioids, co- sleep problems report mental distress, alcohol use, and — caine, caffeine, and cannabis have on sleep parameters measured by symptoms of depression, and anxiety.1,2 In addition, sleep polysomnography (PSG) and related clinical manifestations. problems have been shown to be associated with suicidal Methods: We used electronic databases such as PubMED and 3 PsycINFO to search for relevant articles. We only included studies that thoughts or behaviors. A meta-analysis of 19 studies found assessed sleep disturbances using polysomnography and reviewed the that sleep deprivation affects mood to an even greater extent effects of these substances on six clinically relevant sleep parameters: than it affects cognitive and motor function.
    [Show full text]
  • Rapid Eye Movement Sleep and Slow Wave Sleep Rebounded and Related
    www.nature.com/scientificreports OPEN Rapid eye movement sleep and slow wave sleep rebounded and related factors during positive airway pressure therapy Jin‑Xiang Cheng*, Jiafeng Ren, Jian Qiu, Yingcong Jiang, Xianchao Zhao, Shuyu Sun & Changjun Su* This study aimed to investigate the clinical characteristics and predictors of increased rapid eye movement (REM) sleep or slow wave sleep (SWS) in patients with obstructive sleep apnea (OSA) following positive airway pressure (PAP) therapy. The study retrospectively analyzed data from patients with OSA who underwent both diagnostic polysomnography (PSG) and pressure titration PSG at the Tangdu Hospital Sleep Medicine Center from 2011–2016. Paired diagnostic PSG and pressure titration studies from 501 patients were included. REM rebound was predicted by a higher oxygen desaturation index, lower REM proportion, higher arousal index, lower mean pulse oxygen 2 saturation (SpO2), higher Epworth sleepiness score and younger age (adjusted R = 0.482). The SWS rebound was predicted by a longer total duration of apneas and hypopneas, lower N3 duration, lower 2 SpO2 nadir, lower REM proportion in diagnostic PSG and younger age (adjusted R = 0.286). Patients without REM rebound or SWS rebound had a high probability of comorbidities with insomnia and mood complaints. Some parameters (subjective and objective insomnia, excessive daytime sleepiness, age and OSA severity) indicate changes in REM sleep and SWS between diagnostic and titration PSG tests. Treatment of insomnia and mood disorders in patients with OSA may helpful to improve the use PAP. Obstructive sleep apnea (OSA) is characterized by sleep fragmentation due to recurring episodes of upper airway obstruction with frequent oxygen desaturation.
    [Show full text]
  • REM) Rebound on Initial Exposure to CPAP Therapy: a Systematic Review and Meta-Analysis Gaurav Nigam1*, Macario Camacho2 and Muhammad Riaz3
    Nigam et al. Sleep Science and Practice (2017) 1:13 Sleep Science and Practice DOI 10.1186/s41606-017-0014-7 REVIEW Open Access Rapid Eye Movement (REM) rebound on initial exposure to CPAP therapy: a systematic review and meta-analysis Gaurav Nigam1*, Macario Camacho2 and Muhammad Riaz3 Abstract Objective: Rapid Eye Movement (REM) rebound is a polysomnographic phenomenon where a substantial increase in REM sleep is noted in patients with untreated obstructive sleep apnea (OSA) when first undergoing continuous positive airway pressure (CPAP) titration. The objectives of this study are to determine: 1) the percentage of patients experiencing REM rebound during CPAP titrations, 2) to quantify the relative increase in REM sleep duration and 3) to identify if there are patient variables associated with REM rebound. Methods: Four databases (including PubMed/Medline) were systematically searched through March 12, 2017. Results: Four hundred sixty-seven articles were screened, 58 were reviewed in full-text form and 14 studies met the criteria for inclusion in this review. Eleven of the fourteen studies noted a statistically significant increase in amount of REM sleep during the titration night, compared to baseline sleep study. Pre- and post-CPAP REM sleep duration percentage means ± standard deviations (M ± SD) in 1119 patients increased from 13.8 ± 8.2% to 20.0 ± 10.1%; random effects modeling demonstrated a mean difference of 7.86 (%) [95% CI 5.01, 10.70], p-value <0.00001, corresponding to a 57% relative increase in REM sleep duration. The standardized mean difference (SMD) is 0.90 [95% CI 0.59, 1.22], representing a large magnitude of effect.
    [Show full text]